Related Experiment Video
Updated: Apr 7, 2026

08:30
Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots
Published on: June 2, 2015
9.9K
Encapsulated Pterostilbene in pH-Sensitive Alginate Beads for LDL Oxidation Inhibition and Antioxidant Protection
Rener Mateus Francisco Duarte1,2,3, Jéssica Maria Pereira1, Livia Maria Santos de Lima1
1Strategic Materials Laboratory, Institute of Physics, Federal University of Alagoas, Maceió 57072-900, AL, Brazil.
ACS Omega
|April 6, 2026
Summary
Alginate microcapsules enhance pterostilbene
Area of Science:
- Biomaterials Science
- Nutraceuticals
- Cardiovascular Research
Background:
- Bioactive compounds from fruits and vegetables, like pterostilbene, offer health benefits.
- Pterostilbene, found in blueberries, has antioxidant and anti-inflammatory properties for cardiovascular health.
- Poor stability and bioavailability limit pterostilbene's clinical use.
Purpose of the Study:
- To encapsulate pterostilbene in alginate-based microcapsules.
- To improve pterostilbene's stability and bioavailability for cardiovascular applications.
- To develop a pH-responsive delivery system for controlled release.
Main Methods:
- Pterostilbene encapsulation using alginate and ionic gelation.
- Characterization via scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FTIR).
- In vitro antioxidant assays (DPPH, FRAP, ORAC) and LDL oxidation inhibition assays (TBARS).
Main Results:
- High encapsulation efficiency of 95.6% achieved.
- Microcapsules demonstrated stability in acidic conditions and pH-responsive release.
- Encapsulation significantly boosted antioxidant activity and LDL oxidation inhibition.
Conclusions:
- Alginate microcapsules effectively protect pterostilbene and enhance its bioactivity.
- This delivery system shows promise for improving cardiovascular health.
- Alginate-based systems offer a viable strategy for delivering bioactive compounds.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
310
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
310
Bioavailability Enhancement: Drug Permeability Enhancement
308
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
308

